Tardive akathisia related to the anti-hypertensive agent Sevikar-a case report.

CONCLUSIONS: It is noteworthy that her TA developed before receiving any antidepressant medication, and that her TA improved after discontinuation of Sevikar. In light of these pharmacodynamic properties, it is therefore concluded that use of amlodipine and olmesartan might have caused TA in this patient. We reported this rare case to remind clinicians to be aware of possible akathisia when using amlodipine and olmesartan in combination as anti-hypertensive agents. PMID: 28583166 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28583166?dopt=Abstract

Source: BMC Pharmacology and Toxicology - June 8, 2017 Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research